In the face of mounting geopolitical tensions between the United States and China, a new Nature commentary calls for renewed efforts to preserve and enhance cross-border collaboration in scientific research.
Scientists led by UC San Diego have developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer, autoimmune diseases and much more. By knocking out a gene circuit responsible for producing lactic acid—a metabolite that makes the cells’ environment toxic—researchers eliminate a primary hurdle in developing cells that can produce higher amounts of pharmaceuticals like Herceptin and Rituximab, without compromising their growth or energy production.
UC San Diego Assistant Professors Itay Budin and Christopher Obara have been named Allen Distinguished Investigators by the Paul G. Allen Family Foundation. The pair will receive $1.5 million over three years to develop visualization and tracking techniques to observe key cellular functions in unprecedented detail.
New research led by UC San Diego’s Scripps Institution of Oceanography highlights the critical role of mangroves in protecting coastal communities from the devastating effects of climate change—particularly hurricanes.
The way scientists think about fusion changed forever in 2022, when what some called the experiment of the century demonstrated for the first time that fusion can be a viable source of clean energy. But a whole host of engineering challenges must be addressed before fusion can be scaled up to become a safe, affordable source of virtually unlimited clean power. In other words, it’s engineering time.
UC San Diego Health one of a few health care systems on West Coast to offer new gene therapy for hemophilia B.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
